Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

September 1, 2007

View Archives Issues

  • Stand and deliver: Vaccine standing orders program boosts immunizations

    Determined to improve a dropping in-hospital vaccination rate for pneumococcal polysaccharide vaccinations, University of Pittsburgh Medical Center-Presbyterian (UPMC-P) went on the cutting edge nationally to design and implement a pharmacist-run inpatient program that successfully reversed the trend.
  • Unsafe drug orders slipping through in Pennsylvania

    A voluntary assessment of electronic pharmacy systems in Pennsylvania facilities showed the systems are not detecting all unsafe drug orders, Pennsylvania's Patient Safety Authority reports . The authority said all Pennsylvania facilities should test their systems to ensure they are catching potentially harmful medication errors.
  • Know what questions to ask to assess drug interaction

    Researchers at the University of Washington have developed a 10-question format as part of a Drug Interaction Probability Scale (DIPS) to provide a guide to evaluating drug interaction causation in specific patients. (See Drug Utilization Review, May 2007, p. 39) DIPS is intended to be used to assist practitioners in assessing drug interaction-induced adverse outcomes.
  • News Briefs

    Pharmacy groups create pandemic flu guide; Medication database may help in disasters; German hospital tests RFID drug tracking; Pharmacists gain input into Joint Commission revision
  • New FDA Approvals

    The Food and Drug Administration recently announced the following approvals:
  • Drug Criteria & Outcomes: Retapamulin (Altabax™) Formulary Evaluation 

    FDA Approved Indication: Retapamulin: For adults and pediatric patients aged nine months and older for impetigo (up to 100 cm2 of total area in adults or 2% total body surface area in pediatric patients) due to methicillin-susceptible Staphylococcus aureus or Streptococcus pyogenes.